GLP-1 medications are considered long-term, chronic-disease therapies for both diabetes and obesity
Goldman Sachs projects that oral GLP-1s will generate roughly $22 billion in annual sales by 2030, capturing about 24% of the global weight-loss drug market, which they expect to be worth $95 billion
Support in Muscle Cell Differentiation These peptides are instrumental in promoting cell growth and differentiation
Arase T, Uchida H, Kajitani T, Ono M, Tamaki K, Oda H, et al
For systemic or injectable use, the safest guidance this article can offer is that it falls outside the validated evidence base and should not be undertaken casually
CJC-1295 Purported Benefits: Increased muscle mass Fat loss Enhanced recovery Anti-aging effects Potential Risks and Complications: Hormonal Imbalances: Overstimulating growth hormone can lead to conditions like acromegaly, diabetes, and thyroid dysfunction